CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy

CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Бібліографічні деталі
Автор:	Eva, Israt Ara Jannat
Інші автори:	Rahman, Kazi Fatema
Формат:	Дисертація
Мова:	English
Опубліковано:	Brac University 2023
Предмети:	CRISPR/Cas9 mechanism In vivo and in vitro modeling CRISPR/Cas9 delivery Mutation targeting in cancer and DMD Chromosomal rearrangement Mouse modeling Off-target limitation DMD mutation in human iPSCs Myoediting of DMD Therapeutic application of CRISPR Molecular genetics Cancer > Treatment
Онлайн доступ:	http://hdl.handle.net/10361/17764

Схожі ресурси

A review on CRISPR-Cas system based applications in Oncology
за авторством: Sadia, Mir
Опубліковано: (2022)

CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
за авторством: Maria, Amatul
Опубліковано: (2020)

Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
за авторством: Nwabunwanne, Eze Uchenna
Опубліковано: (2022)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
за авторством: Shaikat, Mahdi Mubin
Опубліковано: (2023)

CRISPR/Cas9 genome editing to treat sickle cell disease
за авторством: Ullah, Mohammad
Опубліковано: (2023)

A review on CRISPR Technology as an Antiviral Tool
за авторством: Srishti, Sanjida Ahmed
Опубліковано: (2023)

A review paper on Nanotechnology based strategies in the treatment of cancer
за авторством: Rahman, Samia
Опубліковано: (2022)

Biased acquisition of spacers by the CRISPR System of the V. cholerae
за авторством: Supan, Erena Tuzneen, та інші
Опубліковано: (2021)

Analysis and comparison between the Genome of CRISPR bacteriophages
за авторством: Muntaha, Mumtasin
Опубліковано: (2021)

Distribution of complete CRISPR-Cas systems in vibrio cholerae and its effect on presence of plasmid derived contigs in complete genome assemblies
за авторством: Reza, Ratul
Опубліковано: (2024)

Trend in approval of targeted biologics in the last two decades
за авторством: Siddika, Khadiza
Опубліковано: (2024)

Exploring the possible function and acquisition pattern of self-targeting Spacers: in five common infectious bacteria
за авторством: Kenneth, Mutebi John
Опубліковано: (2019)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
за авторством: Bristy, Israt Zerin
Опубліковано: (2021)

A comprehensive in silico investigation into the pathogenic SNPs in RTEL1 gene and their biological consequences
за авторством: Tanshee, Rifah Rownak
Опубліковано: (2023)

The microbial models of molecular biology
за авторством: Davis, Rowland H.

SIRT6 and cancer stem cells: is there any implication?
за авторством: Sarker, Tanosi
Опубліковано: (2022)

Assessing the interspecies and intraspecies diversity of Cas1 and Cas3 proteins of the CRISPR-Cas system in vibrio cholera and Escherichia coli strains
за авторством: Tabassum, Tahani, та інші
Опубліковано: (2022)

Genetic disorders associated with mutations in bHLH transcription factors: a review
за авторством: Joya, Mollika Bharadwaj
Опубліковано: (2023)

Exploring of deletion mutation causative for Duchenne Muscular Dystrophy (DMD) in Bangladesh cohort
за авторством: Eshaque, Tamannyat Binte
Опубліковано: (2024)

A review on targeted therapies for lung cancer
за авторством: Ashraf, Anushey
Опубліковано: (2023)

Molecules associated with the development of lung cancer
за авторством: Rahman, Adree, та інші
Опубліковано: (2023)

Inside the human genome
за авторством: Avise, John C.

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
за авторством: Nahar, Kamrun
Опубліковано: (2023)

State of Thalassemia in Bangladesh: a review
за авторством: Reedoy, Md. Shariqul Islam
Опубліковано: (2022)

Carcinogenesis

Molecular biology of cancer : mechanisms, targets, and therapeutics /
за авторством: Pecorino, Lauren
Опубліковано: (2012)

Molecular biology of the gene /
Опубліковано: (2004)

Introduction to genetic analysis /
Опубліковано: (2012)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
за авторством: Meem, Manila
Опубліковано: (2023)

iGenetics : a molecular approach /
за авторством: Russell, Peter J.
Опубліковано: (2006)

iGenetics : a molecular approach /
за авторством: Russell, Peter J.
Опубліковано: (2010)

Modern genetic analysis : integrating genes and genomes /
за авторством: Griffiths, Anthony J. F.
Опубліковано: (2002)

Targeted therapeutic options in the treatment of Breast Cancer
за авторством: Alam, Kazi Tasnuva
Опубліковано: (2022)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
за авторством: Paul, Pulock
Опубліковано: (2024)

The current cancer situation in metropolitan Dhaka
за авторством: Morshid, Golam
Опубліковано: (2023)

Molecular biology and biotechnology : a guide for teachers /
за авторством: Kreuzer, Helen
Опубліковано: (2008)

Banking credit for farm inputs marketing business : macro perspective and micro realities / Bhupat M. Desai, N.V. Namboodiri.
за авторством: Desai, B. M. 1938
Опубліковано: (1996)

Repurposing Albendazole and Mebendazole, an antiparasitic drug in treating colorectal cancer- a review
за авторством: Mondal, Shawon
Опубліковано: (2023)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
за авторством: Karim, Azrin
Опубліковано: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
за авторством: Tania, Umme
Опубліковано: (2023)